Last year we submitted one NDA and one PMA. One of our clients submitted a BLA. These submissions used Target e*CRF® as the EDC tool for the pivotal trials. Already this year we have submitted one IND and a 2nd IND is going in this week. One of our clients is submitting an NDA this quarter which also used Target e*CRF® as the EDC tool for all of the clinical trials. We now also represent over 25 companies at FDA. Our regulatory group is headed by Dr. Glen Park with a strong team including: Mary Shatzoff, Fredy Varela, Daisy Sun, and Carlos Figueroa.